Prevalence of heart failure in Australia: a systematic review

Sahle, Berhe W.; Owen, Alice; Mutowo, Mutsa; Krum, Henry; Reid, Christopher M.

doi:10.1186/s12872-016-0208-4

Cited by 80 publications

(68 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…4,18 In South America the HF prevalence is 1 % and in Australia it ranges between 1 % and 2 %, similar to Western countries (see Figure 2). 19,20 Although aetiologies and clinical characteristics have been studied in Sub-Saharan Africa, 21 there are actually no population studies providing insight into prevalence or incidence . are considered (see Figure 3).…”

Section: Prevalence and Incidencementioning

confidence: 99%

Global Public Health Burden of Heart Failure

Savarese

Lund

2017

Cardiac Failure Review

2,139

1,366

View full text Add to dashboard Cite

EpidemiologyAccess at: www.CFRjournal.com Heart failure (HF) is a complex clinical syndrome characterised by the reduced ability of the heart to pump and/or fill with blood. In this review we describe the epidemiology of HF, providing data about the prevalence, incidence, mortality and morbidity worldwide. Prevalence and IncidenceCurrently 5.7 million people in the US have HF, but the projections are worrisome since it is expected that by 2030 more than 8 million people will have this condition, accounting for a 46 % increase in prevalence (see Figure 1). In Japan around 1 million people have the condition, accounting for 1 % of the population. [14][15][16] In India the estimates range between 1.3 and 4.6 million, which translates to a prevalence of 0.12-0.44 %, although this may be underestimated. 17 In Southeast Asia 9 million people have HF; with a prevalence of 6.7 % in Malaysia and 4.5 % in Singapore. 4,18 In South America the HF prevalence is 1 % and in Australia it ranges between 1 % and 2 %, similar to Western countries (see Figure 2). 19,20Although aetiologies and clinical characteristics have been studied in Sub-Saharan Africa, 21 there are actually no population studies providing insight into prevalence or incidence . AbstractHeart failure (HF) is a global pandemic affecting at least 26 million people worldwide and is increasing in prevalence. HF health expenditures are considerable and will increase dramatically with an ageing population. Despite the significant advances in therapies and prevention, mortality and morbidity are still high and quality of life poor. The prevalence, incidence, mortality and morbidity rates reported show geographic variations, depending on the different aetiologies and clinical characteristics observed among patients with HF. In this review we focus on the global epidemiology of HF, providing data about prevalence, incidence, mortality and morbidity worldwide.

show abstract

Section: Prevalence and Incidencementioning

confidence: 99%

Global Public Health Burden of Heart Failure

Savarese

Lund

2017

Cardiac Failure Review

2,139

1,366

View full text Add to dashboard Cite

show abstract

“…The prevalence of congestive cardiac failure (CCF) is estimated to be around 1%‐2% in Australia . There were over fifty thousand hospital separations for heart failure recorded in a 1‐year period between 2012 and 2013.…”

Section: Introductionmentioning

confidence: 99%

Outcomes of hospital in the home treatment of acute decompensated congestive cardiac failure compared to traditional in‐hospital treatment in older patients

Sunderland

2019

Australas J Ageing

View full text Add to dashboard Cite

Objectives To compare the outcomes of readmission, mortality and treatment‐related complications in older people treated by hospital in the home (HITH) for acute decompensated congestive cardiac failure (CCF) with those treated in hospital. Methods Retrospective cohort study of patients 65 years and older treated by HITH over a 30‐month period compared with age‐ and sex‐matched patients treated in hospital. Results There was no difference between the “HITH” and “Hospital” cohorts in mortality within 60 days of discharge (P = 0.5), time to death (P = 0.8), 30‐day (P = 0.7) and 60‐day (P = 0.4) readmissions, time to readmission (P = 0.9) and complication rate (P = 0.1). HITH patients had longer length of stay (P = 0.001) but lower cost per day of admission ($669.42 vs $1377.58). Conclusion In appropriately selected older patients, HITH is a safe, efficacious and cost‐effective alternative to inpatient management of acute decompensated CCF.

show abstract

“…In Australia, it is estimated that 30 000 people receive a diagnosis of chronic HF each year (National Heart Foundation, 2013), and the prevalence of HF in Australia is similar to that of other industrialized countries, ranging between 1.0 and 2% with a significant proportion of cases being previously undiagnosed. (Ponikowski et al, 2014;Sahle, Owen, Mutowo, Krum, & Reid, 2016). A concerning trend that has been recently noted is that HF is starting to affect people at a younger age, with its incidence doubling from 3 to 6% between 2008 and 2012 for those <51 years of age (Christiansen et al, 2017).…”

mentioning

confidence: 99%

Effectiveness of cognitive behavior therapy for patients with heart failure and depression: A systematic review protocol

Shabu

Jayasekara

2019

Nursing & Health Sciences

View full text Add to dashboard Cite

The objective of this review is to determine the effectiveness of cognitive behavior therapy for patients with heart failure and depression, aged ≥18 years, in institutionalized healthcare settings. More specifically, the review aims to identify which cognitive behavior therapy strategy/strategies, including the method of delivery, is the most effective for the management of depression in hospitalized patients with heart failure. The review question is as follows: Is cognitive behavior therapy effective in reducing symptoms of depression in patients with heart failure? This systematic review will be conducted in accordance with the Joanna Briggs Institute methodology for systematic reviews of effectiveness evidence. This review only includes randomized controlled trials assessing the effectiveness of cognitive behavior therapy as a treatment for depression in adults (aged ≥18 years) with heart failure, compared with usual care, which might include medications.

show abstract

Prevalence of heart failure in Australia: a systematic review

Cited by 80 publications

References 34 publications

Global Public Health Burden of Heart Failure

Global Public Health Burden of Heart Failure

Outcomes of hospital in the home treatment of acute decompensated congestive cardiac failure compared to traditional in‐hospital treatment in older patients

Effectiveness of cognitive behavior therapy for patients with heart failure and depression: A systematic review protocol

Contact Info

Product

Resources

About